PET/MRI

You have access
Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial
Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso and Andreas Kjaer

Journal of Nuclear Medicine March 1, 2021, 62 (3) 354-359; DOI: https://doi.org/10.2967/jnumed.120.248120
You have access
Multimodal Imaging of 2-Cycle PRRT with ¹⁷⁷Lu-DOTA-JR11 and ¹⁷⁷Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model
Jakob Albrecht, Samantha Exner, Carsten Grötzinger, Sonal Prasad, Frank Konietschke, Nicola Beindorff, Anja A. Kühl, Vikas Prasad, Winfried Brenner and Eva J. Koziolek

Journal of Nuclear Medicine March 1, 2021, 62 (3) 393-398; DOI: https://doi.org/10.2967/jnumed.120.250274
You have access
Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing
Stephanie L. Pugh and Pedro Torres-Saavedra

Journal of Nuclear Medicine February 19, 2021, jnumed.120.245654; DOI: https://doi.org/10.2967/jnumed.120.245654
You have access
¹⁸F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with ¹⁸F-FDG PET/CT as reference standard
Martijn Vincent Verhagen, Leon J Menezes, Deena Neriman, Tom A Watson, Shonit Punwani, Stuart A Taylor, Ananth Shankar, Stephen Daw and Paul D Humphries

Journal of Nuclear Medicine February 19, 2021, jnumed.120.260059; DOI: https://doi.org/10.2967/jnumed.120.260059
You have access
Lymph node staging with a combined protocol of ¹⁸F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma
Matthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, Stefan Kommoss, Konstantin Nikolaou, Samine Sahbai, Christian la Fougere, Sara Yvonne Brucker and Helmut Dittmann

Journal of Nuclear Medicine January 28, 2021, jnumed.120.255919; DOI: https://doi.org/10.2967/jnumed.120.255919
You have access
Predicting Gemcitabine Delivery by ¹⁸F-FAC PET in Murine Models of Pancreatic Cancer
James Russell, Milan Grkovski, Isabella J. O’Donoghue, Teja M. Kalidindi, Nagavarakishore Pillarsetty, Eva M. Burnazi, Amanda Kulick, Amber Bahr, Qing Chang, H. Carl LeKaye, Elisa de Stanchina, Kenneth H. Yu and John L. Humm

Journal of Nuclear Medicine February 1, 2021, 62 (2) 195-200; DOI: https://doi.org/10.2967/jnumed.120.246926
You have access
The Evolution of PET/MR is Hindered by our Field’s Reluctance to Provide Critical Evaluation
Adam L. Kesner

Journal of Nuclear Medicine January 15, 2021, jnumed.120.260950; DOI: https://doi.org/10.2967/jnumed.120.260950
You have access
Investigating Low-Dose Image Quality in Whole-Body Pediatric ¹⁸F-FDG Scans Using Time-of-Flight PET/MRI
Jeffrey P. Schmall, Suleman Surti, Hansel J. Otero, Sabah Servaes, Joel S. Karp and Lisa J. States

Journal of Nuclear Medicine January 1, 2021, 62 (1) 123-130; DOI: https://doi.org/10.2967/jnumed.119.240127
You have access
PET/MRI versus PET/CT for Whole-Body Staging
Stephen K Gerard

Journal of Nuclear Medicine October 9, 2020, jnumed.120.256453; DOI: https://doi.org/10.2967/jnumed.120.256453
You have access
First experience using F-18-flubrobenguane PET imaging in patients with the suspicion of pheochromocytoma or paraganglioma
Lukas Kessler, Anna Melissa Schlitter, Markus Kroenke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon P Robinson, Cesare Orlandi, Michael Herz, Behrooz H Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber and Christoph Rischpler

Journal of Nuclear Medicine August 28, 2020, jnumed.120.248021; DOI: https://doi.org/10.2967/jnumed.120.248021

Main menu

User menu

Search

PET/MRI

Pages